Xalud Therapeutics' Series A Round

Xalud Therapeutics raised a round of funding on June 25, 2015. Investors include PBM Capital Group.

Xalud Therapeutics is an IND-stage platform gene therapy company developing novel therapies with several promising therapeutic programs for inflammatory and autoimmune diseases including neuropathic p…

Articles about Xalud Therapeutics' Series A Round: